Half-year report · HY
2370.TEDINET S100Y3SH
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥414m | 2025-10-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥810m | 2024-10-01 → 2025-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥405m | 2024-10-01 → 2025-03-31 | Standalone | Net sales |
| Operating income | −¥630m | 2025-10-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥756m | 2024-10-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥517m | 2025-10-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥711m | 2024-10-01 → 2025-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥550m | 2025-10-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥704m | 2024-10-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥551m | 2025-10-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2024-10-01 → 2025-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥706m | 2024-10-01 → 2025-03-31 | Standalone | Profit loss |
| Total assets | ¥4.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2025-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥413m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥476m | at 2025-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥3.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥4.4bn | at 2025-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2024-09-30v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥653m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥754m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥561m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥565m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥350m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥3m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.06 | 2025-10-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.15 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.67 | 2024-10-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.4% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.8% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 277,417,319 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 264,729,198 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 264,729,198 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥279m |
| Cellular And Tissue Based Product Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥276,000 |
| Cellular And Tissue Based Product Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥276,000 |
| Cellular And Tissue Based Product Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥177m |
| Contract Cell Manufacturing Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥414m |
| Contract Cell Manufacturing Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥414m |
| Contract Cell Manufacturing Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥174m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥414m |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥414m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | −¥351m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥307m |
| Cellular And Tissue Based Product Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥186,000 |
| Cellular And Tissue Based Product Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥186,000 |
| Cellular And Tissue Based Product Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥217m |
| Contract Cell Manufacturing Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| Contract Cell Manufacturing Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| Contract Cell Manufacturing Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥232m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | −¥448m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 468
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for share based payments ncl | InterimInstant_NonConsolidatedMember | 10825000 | JPY |
| Other ncl | Prior1YearInstant_NonConsolidatedMember | 15546000 | JPY |
| Other ncl | InterimInstant_NonConsolidatedMember | 75000 | JPY |
| Noncurrent liabilities | Prior1YearInstant_NonConsolidatedMember | 243387000 | JPY |
| Noncurrent liabilities | InterimInstant_NonConsolidatedMember | 174124000 | JPY |
| Liabilities | Prior1YearInstant_NonConsolidatedMember | 476497000 | JPY |
| Liabilities | InterimInstant_NonConsolidatedMember | 412886000 | JPY |
| Capital stock | Prior1YearInstant_NonConsolidatedMember | 5102250000 | JPY |
| Capital stock | InterimInstant_NonConsolidatedMember | 3930916000 | JPY |
| Capital surplus | Prior1YearInstant_NonConsolidatedMember | 3850000 | JPY |
| Capital surplus | InterimInstant_NonConsolidatedMember | 186954000 | JPY |
| Retained earnings | Prior1YearInstant_NonConsolidatedMember | -1362138000 | JPY |
| Retained earnings | InterimInstant_NonConsolidatedMember | -551351000 | JPY |
| Treasury stock | Prior1YearInstant_NonConsolidatedMember | -4000 | JPY |
| Treasury stock | InterimInstant_NonConsolidatedMember | -4000 | JPY |
| Shareholders equity | Prior1YearInstant_NonConsolidatedMember | 3743957000 | JPY |
| Shareholders equity | InterimInstant_NonConsolidatedMember | 3566515000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant_NonConsolidatedMember | 33615000 | JPY |
| Valuation difference on available for sale securities | InterimInstant_NonConsolidatedMember | -1854000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant_NonConsolidatedMember | 33615000 | JPY |
| Valuation and translation adjustments | InterimInstant_NonConsolidatedMember | -1854000 | JPY |
| Subscription rights to shares | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Subscription rights to shares | InterimInstant_NonConsolidatedMember | 9911000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember | 3777572000 | JPY |
| Net assets | InterimInstant_NonConsolidatedMember | 3574573000 | JPY |
| Liabilities and net assets | Prior1YearInstant_NonConsolidatedMember | 4254070000 | JPY |
| Liabilities and net assets | InterimInstant_NonConsolidatedMember | 3987459000 | JPY |
| Net sales | Prior1InterimDuration_NonConsolidatedMember | 404787000 | JPY |
| Net sales | InterimDuration_NonConsolidatedMember | 414046000 | JPY |
| Cost of sales | Prior1InterimDuration_NonConsolidatedMember | 345806000 | JPY |
| Cost of sales | InterimDuration_NonConsolidatedMember | 297543000 | JPY |
| Gross profit | Prior1InterimDuration_NonConsolidatedMember | 58981000 | JPY |
| Gross profit | InterimDuration_NonConsolidatedMember | 116503000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration_NonConsolidatedMember | 814860000 | JPY |
| Selling general and administrative expenses | InterimDuration_NonConsolidatedMember | 746382000 | JPY |
| Operating income | Prior1InterimDuration_NonConsolidatedMember | -755879000 | JPY |
| Operating income | InterimDuration_NonConsolidatedMember | -629879000 | JPY |
| Interest income noi | Prior1InterimDuration_NonConsolidatedMember | 6125000 | JPY |
| Interest income noi | InterimDuration_NonConsolidatedMember | 7804000 | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1InterimDuration_NonConsolidatedMember | 3100000 | JPY |
| Reversal of allowance for doubtful accounts noi | InterimDuration_NonConsolidatedMember | 2500000 | JPY |
| Gain on investments in partnership noi | Prior1InterimDuration_NonConsolidatedMember | 30181000 | JPY |
| Gain on investments in partnership noi | InterimDuration_NonConsolidatedMember | 103893000 | JPY |
| Income for cancellation of manufacturing noi | Prior1InterimDuration_NonConsolidatedMember | 5350000 | JPY |
| Income for cancellation of manufacturing noi | InterimDuration_NonConsolidatedMember | 3093000 | JPY |
| Other noi | Prior1InterimDuration_NonConsolidatedMember | 1817000 | JPY |
| Other noi | InterimDuration_NonConsolidatedMember | 2819000 | JPY |
| Non operating income | Prior1InterimDuration_NonConsolidatedMember | 46573000 | JPY |
| Non operating income | InterimDuration_NonConsolidatedMember | 120110000 | JPY |
| Interest expenses noe | Prior1InterimDuration_NonConsolidatedMember | 5000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |